Search Results

Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.

NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect’s family of products.

Lifecore Biomedical, Inc. announced it has reached a cooperation agreement with 22NW, LP, which provides for the addition of Humberto Antunes, Jason Aryeh, Paul Johnson and Matthew Korenberg to the Board of Directors of the Company effective immediately following the 2023 Annual Meeting of Stockholders.

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency of single-cell RNA sequencing (scRNA-seq) analysis of rare cell populations.